MedPath

Booster Dose of HCG for Unruptured Follicle in Non IVF/ICSI Cycles

Phase 4
Completed
Conditions
LUF - Luteinised Unruptured Follicle Syndrome
Interventions
Drug: Saline Solution
Registration Number
NCT03580031
Lead Sponsor
Tanta University
Brief Summary

This study will be conducted to assess the effect of booster dose of hCG on the unruptured follicles in non IVF/ICSI cycles.

Detailed Description

In this study enrolled patients (n=160) who underwent controlled ovarian stimulation and timed intercourse with unruptured mature graffian follicle 48 hours after IM 10,000 IU HCG dose. Patients were allocated randomly into intervention group and control group. In the intervention group another booster dose (10,000 IU of hCG) was given IM while in the control group 2 ml normal saline was given IM leaving follicles for spontaneous rupture

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
110
Inclusion Criteria
  • Ordinary stimulated cycles
  • IUI stimulated cycles
  • Unruptured follicle after 10000 IU IM HCG triggering
Exclusion Criteria
  • IVF/ICSI cycles

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupSaline SolutionSaline 2m Injection im 48 hours after the first triggering dose
Study grouphCGHCG IM 10,000 IU Im 48 hours after first triggering dose
Primary Outcome Measures
NameTimeMethod
Ovulation rate48 hours

rupture of dominant follicle manifested by disappearance of follicle and presence of free fluid in douglas pouch

Secondary Outcome Measures
NameTimeMethod
Pregnancy rate15 days

Number of cases with positive serum pregnancy test

Trial Locations

Locations (1)

Ayman Shehata Dawood

🇪🇬

Tanta, Algharbia, Egypt

© Copyright 2025. All Rights Reserved by MedPath